MoSe2 Promotes Pyroptosis-Associated Intratumoral Immune-Cell Infiltration in Vemurafenib-Resistant Melanoma

Acquired resistance to BRAF inhibitors such as vemurafenib remains a major challenge in the treatment of BRAF-mutant melanoma. Although mitochondrial dysfunction-mediated pyroptosis has emerged as a potential strategy for overcoming drug resistance, whether MoSe2 possesses intrinsic antitumor activity in the absence of external stimulation remains largely unexplored. Here, we demonstrate that MoSe2 reduces viability and induces lytic cell death to a greater extent in vemurafenib-resistant melanoma cells than in parental cells under the treatment conditions tested. Mechanistically, molecular dynamics simulations and experimental analyses reveal that MoSe2 colocalizes with mitochondria and induces mitochondrial stress, which is associated with mitochondrial dysfunction and activation of the caspase-3/GSDME-associated pyroptotic pathway in vitro. In vivo, adding MoSe2 to vemurafenib is associated with increased intratumoral dendritic cell and Tcell infiltration and with enhanced antitumor efficacy, prolonging survival in both subcutaneous and genetically engineered spontaneous melanoma models, with overall tolerability at the tested dose, although urea and hematological changes were observed. Collectively, this work identifies a previously underappreciated light-independent therapeutic activity of MoSe2 and shows that MoSe2-induced mitochondrial dysfunction is accompanied by caspase-3/GSDME-dependent lytic cell death, while adding MoSe2 to vemurafenib is associated with increased intratumoral immune infiltration and enhanced antitumor efficacy in the models tested.

Authors

Institutions

Publication Details

Journal
Antioxidants
Published
2026-11-19
DOI
https://doi.org/10.3390/antiox15111505
Primary Topic
Nanoplatforms for cancer theranostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

MoSe2 Promotes Pyroptosis-Associated Intratumoral Immune-Cell Infiltration in Vemurafenib-Resistant Melanoma

Jiangang Long, Guanfei Zhang, Zongguan Huang, Mo Zhang et al.
Antioxidants
Nanoplatforms for cancer theranostics
article

MoSe2 Promotes Pyroptosis-Associated Intratumoral Immune-Cell Infiltration in Vemurafenib-Resistant Melanoma

Jiangang Long, Guanfei Zhang, Zongguan Huang, Mo Zhang, Yiming Hu, Xiaofei Zhao, Shujun Han, Lanlan Cui, Yongping Shao, Luyao Guo, Changwei Hu, Ying Li, Xiaoyan Qu
article en

Abstract

Acquired resistance to BRAF inhibitors such as vemurafenib remains a major challenge in the treatment of BRAF-mutant melanoma. Although mitochondrial dysfunction-mediated pyroptosis has emerged as a potential strategy for overcoming drug resistance, whether MoSe2 possesses intrinsic antitumor activity in the absence of external stimulation remains largely unexplored. Here, we demonstrate that MoSe2 reduces viability and induces lytic cell death to a greater extent in vemurafenib-resistant melanoma cells than in parental cells under the treatment conditions tested. Mechanistically, molecular dynamics simulations and experimental analyses reveal that MoSe2 colocalizes with mitochondria and induces mitochondrial stress, which is associated with mitochondrial dysfunction and activation of the caspase-3/GSDME-associated pyroptotic pathway in vitro. In vivo, adding MoSe2 to vemurafenib is associated with increased intratumoral dendritic cell and Tcell infiltration and with enhanced antitumor efficacy, prolonging survival in both subcutaneous and genetically engineered spontaneous melanoma models, with overall tolerability at the tested dose, although urea and hematological changes were observed. Collectively, this work identifies a previously underappreciated light-independent therapeutic activity of MoSe2 and shows that MoSe2-induced mitochondrial dysfunction is accompanied by caspase-3/GSDME-dependent lytic cell death, while adding MoSe2 to vemurafenib is associated with increased intratumoral immune infiltration and enhanced antitumor efficacy in the models tested.

AntioxidantsVol. 15(11)
Second Affiliated Hospital of Xi'an Jiaotong University (CN), Xi'an Jiaotong University (CN)
Nanoplatforms for cancer theranostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon